KRS 216B.402: Protocol for treatment of drug overdose -- Cannabinoid hyperemesis

syndrome.

(1) When a person is admitted to a hospital emergency department or hospital

emergency room for treatment of a drug overdose:

(a) The person shall be informed of av ailable substance use disorder treatment

services known to the hospital that are provided by that hospital, other local

hospitals, the local community mental health center, and any other local

treatment programs licensed pursuant to KRS 222.231;

(b) The hospital may obtain permission from the person when stabilized, or the

person's legal representative, to contact any available substance use disorder

treatment programs offered by that hospital, other local hospitals, the local

community mental health center , or any other local treatment programs

licensed pursuant to KRS 222.231, on behalf of the person to connect him or

her to treatment; and

(c) The local community mental health center may provide an on -call service in

the hospital emergency department or hospital emergency room for the person

who was treated for a drug overdose to provide information about services

and connect the person to substance use disorder treatment, as funds are

available. These services, when provided on the grounds of a hospital, shall be

coordinated with appropriate hospital staff.

(2) When a person, who is a registered qualified patient or a visiting qualified patient as

defined in KRS 218B.010, is admitted to a hospital emergency department or a

hospital emergency room for treatm ent of cannabinoid hyperemesis syndrome, the

hospital shall notify the cabinet within forty -eight (48) hours. Notification shall

include the registered qualified patient's or a visiting qualified patient's name and

registry identification card number, if available. The cabinet shall record all cases of

cannabinoid hyperemesis syndrome in the electronic monitoring system established

pursuant to KRS 218A.202.